Financhill
Back

Regeneron Pharmaceuticals, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
53

REGN
Regeneron Pharmaceuticals, Inc.

Last Price:
$737.64
Seasonality Move:
-4.92%

7 Day Trial

ALL ACCESS PASS

$ 7
  • The current trend is moderately bearish and REGN is experiencing buying pressure, which is a positive indicator for future bullish movement.

Regeneron Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 760.92 Sell
20-day SMA: 772.16 Sell
50-day SMA: 743.01 Sell
200-day SMA: 611.14 Buy
8-day EMA: 753.11 Sell
20-day EMA: 760.08 Sell
50-day EMA: 733.06 Buy
200-day EMA: 673.44 Buy

Regeneron Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.63 Buy
Relative Strength Index (14 RSI): 41.7 Sell
Chaikin Money Flow: 458052 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (746.64 - 787.92) Sell
Bollinger Bands (100): (578.23 - 750.05) Buy

Regeneron Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Regeneron Pharmaceuticals, Inc. Stock

Is Regeneron Pharmaceuticals, Inc. Stock a Buy?

REGN Technical Analysis vs Fundamental Analysis

Buy
53
Regeneron Pharmaceuticals, Inc. (REGN) is a Buy

Is Regeneron Pharmaceuticals, Inc. a Buy or a Sell?

Regeneron Pharmaceuticals, Inc. Stock Info

Market Cap:
77.1B
Price in USD:
733.78
Share Volume:
789.3K

Regeneron Pharmaceuticals, Inc. 52-Week Range

52-Week High:
821.11
52-Week Low:
476.49
Buy
53
Regeneron Pharmaceuticals, Inc. (REGN) is a Buy

Regeneron Pharmaceuticals, Inc. Share Price Forecast

Is Regeneron Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Regeneron Pharmaceuticals, Inc.

Is Regeneron Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $3.71 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.04 per share, and an increase next year of $7.98 per share.

Technical Analysis of Regeneron Pharmaceuticals, Inc.

Should I short Regeneron Pharmaceuticals, Inc. stock?

* Regeneron Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.